- Home
- KYMR vs CXT Comparison
KYMR vs CXT Comparison
Compare KYMR & CXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KYMR
- CXT
- Stock Information
- Founded
- KYMR 2015
- CXT 1855
- Country
- KYMR United States
- CXT United States
- Employees
- KYMR N/A
- CXT N/A
- Industry
- KYMR Medicinal Chemicals and Botanical Products
- CXT Office Equipment/Supplies/Services
- Sector
- KYMR Health Care
- CXT Industrials
- Exchange
- KYMR Nasdaq
- CXT Nasdaq
- Market Cap
- KYMR 3.1B
- CXT 3.4B
- IPO Year
- KYMR 2020
- CXT N/A
- Fundamental
- Price
- KYMR $42.63
- CXT $59.61
- Analyst Decision
- KYMR Strong Buy
- CXT Buy
- Analyst Count
- KYMR 16
- CXT 4
- Target Price
- KYMR $58.94
- CXT $77.00
- AVG Volume (30 Days)
- KYMR 622.1K
- CXT 381.6K
- Earning Date
- KYMR 08-11-2025
- CXT 08-06-2025
- Dividend Yield
- KYMR N/A
- CXT 1.14%
- EPS Growth
- KYMR N/A
- CXT N/A
- EPS
- KYMR N/A
- CXT 2.61
- Revenue
- KYMR $44,711,000.00
- CXT $1,537,300,000.00
- Revenue This Year
- KYMR $58.26
- CXT $8.22
- Revenue Next Year
- KYMR N/A
- CXT $8.51
- P/E Ratio
- KYMR N/A
- CXT $22.80
- Revenue Growth
- KYMR N/A
- CXT 10.28
- 52 Week Low
- KYMR $19.45
- CXT $41.54
- 52 Week High
- KYMR $53.27
- CXT $67.01
- Technical
- Relative Strength Index (RSI)
- KYMR 49.94
- CXT 54.39
- Support Level
- KYMR $36.65
- CXT $53.84
- Resistance Level
- KYMR $44.94
- CXT $61.80
- Average True Range (ATR)
- KYMR 1.64
- CXT 1.77
- MACD
- KYMR -0.18
- CXT 0.08
- Stochastic Oscillator
- KYMR 72.14
- CXT 72.49
About KYMR Kymera Therapeutics Inc.
Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.
About CXT Crane NXT Co.
Crane NXT Co is a industrial technology company that provides proprietary and trusted technology solutions to secure, detect, and authenticate what matters to its customers. It is a pioneer in proprietary micro-optics technology for securing physical products, and its sophisticated electronic equipment and associated software leverages proprietary core capabilities with detection and sensing technologies. The company operates in two segments which are Crane Payment Innovations (CPI) and Security and Authentication Technologies.